Today

Agents

Chat

Arena

Discover

More

App

ADC Therapeutics announces Zynlonta updates in Japan - ADCT News | Rallies

ADC Therapeutics announces Zynlonta updates in Japan

ADCT•2026-10-29

ADC Therapeutics said Tanabe Pharma entered an exclusive sublicensing agreement with Nippon Shinyaku for Zynlonta in Japan.

1. Japan sublicensing agreement

Tanabe Pharma entered an exclusive sublicensing agreement with Nippon Shinyaku for ADC Therapeutics’ Zynlonta in Japan.

Related News

FirstService study finds homes in amenity-rich communities sell for up to 46.1% more

FSV•2026-10-29

Immunocore to present Phase 1 data on brenetafusp-Kimmtrak combination in metastatic uveal melanoma at SITC

IMCR•2026-10-29

Canadian dollar weakens, benchmark yield climbs

TLT

•

2026-10-29

Fiduciary Trust International welcomes Jeffrey Danile as national director of trust administration

BEN•2026-10-29

Celularity and Vesalius Longevity Labs sign exclusive collaboration for Peptual peptide APIs manufactured in the United States

CELU•2026-10-29